Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	19.23	46.38	38.89
Graham Fair Price	11.40	13.48	12.10
PEG	-28.67	0.95	-1.33
Price/Book	10.29	3.29	2.98
Price/Cash Flow	911.54	404.83	40.02
Prices/Earnings	-5.89	19.72	20.95
Price/Sales	8.84	6.92	6.36
Price/FCF	911.54	404.83	40.02
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.54	0.34	0.34
Operating Margin	-8.25	0.12	0.13
ROA	17.45	0.03	0.03
ROE	0.04	0.04	17.19
ROIC	0.04	0.04	4.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.14	-0.68	-79.00
Dividends QOQ	0.00	< 0.005	100.00
EBIT QOQ	0.04	-0.05	20.45
EPS QOQ	-0.16	0.21	31.94
FCF QOQ	-0.19	-0.89	-360.68
Revenue QOQ	-0.04	0.04	7.06
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	84.21	83.18	-1.22
Days Sales Outstanding (DSO)	55.52	58.08	4.63
Inventory Turnover	1.07	1.08	1.24
Debt/Capitalization	0.03	0.04	10.89
Quick Ratio	1.32	1.36	2.41
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.53	13.92	2.91
Cash	1.32	1.22	-7.21
Capex	-0.21	-0.12	42.72
Free Cash Flow	1.01	0.11	-88.78
Revenue	6.33	6.61	4.28
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.37	2.43	2.80
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.83	-0.70	15.91
Naive Interpretation	Member

06 - Financial Health · Bad

Rating